|
1
|
Caldarella A and Barchielli A:
Glioblastoma in the canton of Zurich, Switzerland revisited: 2005
to 2009. Cancer. 122:37402016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Komori T, Sasaki H and Yoshida K: Revised
WHO classification of tumours of the central nervous system:
Summary of the revision and perspective. No Shinkei Geka.
44:625–635. 2016.(In Japanese). PubMed/NCBI
|
|
3
|
Ohgaki H and Kleihues P: Genetic pathways
to primary and secondary glioblastoma. Am J Pathol. 170:1445–1453.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rigamonti A, Imbesi F, Silvani A, Grimod
G, Prone V, Gaviani P, Ardizzoia A, Milanesi I, Arienti V, Agostoni
E, et al: Pattern of care and outcome in elderly patients with
glioblastoma: Data in 151 patients from 3 Lombardia Hospitals. J
Neurol Sci. 378:3–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Komotar RJ, Otten ML, Moise G and Connolly
ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma-A critical review. Clin Med Oncol. 2:421–422.
2008.PubMed/NCBI
|
|
6
|
Khosla D: Concurrent therapy to enhance
radiotherapeutic outcomes in glioblastoma. Ann Transl Med.
4:542016.PubMed/NCBI
|
|
7
|
Marumoto T and Saya H: Molecular biology
of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Piwecka M, Rolle K, Belter A, Barciszewska
AM, Żywicki M, Michalak M, Nowak S, Naskręt-Barciszewska MZ and
Barciszewski J: Comprehensive analysis of microRNA expression
profile in malignant glioma tissues. Mol Oncol. 9:1324–1340. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gu JJ, Fan KC, Zhang JH, Chen HJ and Wang
SS: Suppression of microRNA-130b inhibits glioma cell proliferation
and invasion, and induces apoptosis by PTEN/AKT signaling. Int J
Mol Med. 41:284–292. 2018.PubMed/NCBI
|
|
15
|
Gomez Zubieta DM, Hamood MA, Beydoun R,
Pall AE and Kondapalli KC: MicroRNA-135a regulates NHE9 to inhibit
proliferation and migration of glioblastoma cells. Cell Commun
Signal. 15:552017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng ZX, Song YX, Wang ZY, Wang Y and
Dong Y: miR-144-3p serves as a tumor suppressor by targeting FZD7
and predicts the prognosis of human glioblastoma. Eur Rev Med
Pharmacol Sci. 21:4079–4086. 2017.PubMed/NCBI
|
|
17
|
Xu X, Cai N, Zhi T, Bao Z, Wang D, Liu Y,
Jiang K, Fan L, Ji J and Liu N: MicroRNA-1179 inhibits glioblastoma
cell proliferation and cell cycle progression via directly
targeting E2F transcription factor 5. Am J Cancer Res. 7:1680–1692.
2017.PubMed/NCBI
|
|
18
|
Sun J, Zheng G, Gu Z and Guo Z: MiR-137
inhibits proliferation and angiogenesis of human glioblastoma cells
by targeting EZH2. J Neurooncol. 122:481–489. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu Q, Zhu Q, Zhou Z, Wang Y, Liu X, Yin G,
Tong X and Tu K: MicroRNA-876-5p inhibits epithelial-mesenchymal
transition and metastasis of hepatocellular carcinoma by targeting
BCL6 corepressor like 1. Biomed Pharmacother. 103:645–652. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Xie Y, Li X, Lin J, Zhang S, Li Z,
Huo L and Gong R: MiR-876-5p acts as an inhibitor in hepatocellular
carcinoma progression by targeting DNMT3A. Pathol Res Pract.
214:2024–2030. 2018. View Article : Google Scholar
|
|
21
|
Bao L, Lv L, Feng J, Chen Y, Wang X, Han S
and Zhao H: MiR-876-5p suppresses epithelial-mesenchymal transition
of lung cancer by directly down-regulating bone morphogenetic
protein 4. J Biosci. 42:671–681. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duan N, Hu X, Yang X, Cheng H and Zhang W:
MicroRNA-370 directly targets FOXM1 to inhibit cell growth and
metastasis in osteosarcoma cells. Int J Clin Exp Pathol.
8:10250–10260. 2015.PubMed/NCBI
|
|
23
|
Song BN and Chu IS: A gene expression
signature of FOXM1 predicts the prognosis of hepatocellular
carcinoma. Exp Mol Med. 50:e4182018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang C, Du J and Xie K: FOX M1 and its
oncogenic signaling in pancreatic cancer pathogenesis. Biochim
Biophys Acta. 1845:104–116. 2014.PubMed/NCBI
|
|
25
|
Cao S, Lin L, Xia X and Wu H: MicroRNA-761
promotes the sensitivity of colorectal cancer cells to
5-Fluorouracil through targeting FOXM1. Oncotarget. 9:321–331.
2017.PubMed/NCBI
|
|
26
|
Siraj AK, Pratheeshkumar P, Parvathareddy
SK, Qadri Z, Thangavel S, Ahmed S, Al-Dayel F, Tulbah A, Ajarim D
and Al-Kuraya KS: FoxM1 is an independent poor prognostic marker
and therapeutic target for advanced Middle Eastern breast cancer.
Oncotarget. 9:17466–17482. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou Y, Li W, Sheng Y, Li L, Huang Y, Zhang
Z, Zhu T, Peace D, Quigley JG, Wu W, et al: The transcription
factor Foxm1 is essential for the quiescence and maintenance of
hematopoietic stem cells. Nat Immunol. 16:810–818. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu XF, Zeng, Liang WQ, Chen CF, Sun SM and
Lin HY: FoxM1 is a promising candidate target in the treatment of
breast cancer. Oncotarget. 9:842–852. 2017.PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bowman A and Nusse R: Location, location,
location: FoxM1 mediates beta-catenin nuclear translocation and
promotes glioma tumorigenesis. Cancer Cell. 20:415–416. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang N, Wei P, Gong A, Chiu WT, Lee HT,
Colman H, Huang H, Xue J, Liu M, Wang Y, et al: FoxM1 promotes
beta-catenin nuclear localization and controls Wnt target-gene
expression and glioma tumorigenesis. Cancer Cell. 20:427–442. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Zhang S and Huang S: FoxM1: A
potential drug target for glioma. Future Oncol. 8:223–226. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang N, Wu X, Yang L, Xiao F, Zhang H,
Zhou A, Huang Z and Huang S: FoxM1 inhibition sensitizes resistant
glioblastoma cells to temozolomide by downregulating the expression
of DNA-repair gene Rad51. Clin Cancer Res. 18:5961–5971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Z, Zhang S, Siu TL and Huang S:
Glioblastoma multiforme formation and EMT: Role of FoxM1
transcription factor. Curr Pharm Des. 21:1268–1271. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang SW, Ali ND, Zhong L and Shi J:
MicroRNAs as biomarkers for human glioblastoma: Progress and
potential. Acta Pharmacol Sin. 39:1405–1413. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Banelli B, Forlani A, Allemanni G,
Morabito A, Pistillo MP and Romani M: MicroRNA in glioblastoma: An
overview. Int J Genomics. 2017:76390842017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ahir BK, Ozer H, Engelhard HH and Lakka
SS: MicroRNAs in glioblastoma pathogenesis and therapy: A
comprehensive review. Crit Rev Oncol Hematol. 120:22–33. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu Q, Du K, Mao X and Ning S: miR-197 is
downregulated in cervical carcinogenesis and suppresses cell
proliferation and invasion through targeting forkhead box M1. Oncol
Lett. 15:10063–10069. 2018.PubMed/NCBI
|
|
39
|
Feng J, Wang X, Zhu W, Chen S and Feng C:
MicroRNA-630 suppresses epithelial-to-mesenchymal transition by
regulating FoxM1 in gastric cancer cells. Biochemistry. 82:707–714.
2017.PubMed/NCBI
|
